115
, adn the formatting is not correct. I will provide a response based on the content, but it will be difficult to follow.
AstraZeneca has launched FluMist Home, the first FDA-approved nasal spray flu vaccine for self- or caregiver management. This is a significant advancement as it offers a convenient option for seasonal flu vaccination, especially for those afraid of needles. Approximately 30% of young adults and the majority of children have a fear of needles. The vaccine is available with a prescription for children ages 2 and over, and adults up to age 49. More children died from the flu last season than in any year outside of the 2009 swine flu pandemic, and most of those who died were unvaccinated.
